Blog

Solenic Medical Wins 2024 AAHKS Industry Innovation Award

Written by VIC Team | Nov 11, 2024 7:50:29 PM

Dallas, TX (November 8th, 2024) - Solenic Medical Inc. won the Industry Innovation Award at the 2024 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS) held in Dallas TX, from November 8th to the 9th. Solenic Medical was recognized for it patented technology using alternating magnetic fields (AMF) to generate thermal medical on the surface of the implants, aiming to eradicate biofilms.

The 2024 AAHKS Industry Innovation Award is a competitive product award presented to organizations exhibiting at the AAHKS Annual Meeting. It rewards exhibitors' cutting-edge innovation in orthopaedic hip and knee arthroplasty. This award is given each year to the best creative goods in the Exhibit Hall/Learning Center. Out of 150 exhibiting firms, 27 submissions were received, with Solenic Medical and Guard Medical obtaining the top honor.

“AAHKS is truly excited to grant the Industry Innovation Award to both Solenic Medical and Guard Medical in our third year of the program. It’s very important for industry to have a role in developing innovations in patient care and with 27 entries submitted, I think that’s a great indicator for innovation in the field of hip and knee arthroplasty,” said James I. Huddleston III, MD, AAHKS President.

About Solenic Medical Inc.

Solenic Medical, Inc. is a medical device company developing an innovative non-invasive treatment for infected metallic implants in the body. Using technology invented at the University of Texas Southwestern, Solenic is leveraging the unique properties of alternating magnetic fields (AMF) generated by external coils to reduce, and possibly eradicate, the biofilm on the surface of metallic implants. This non-invasive, non-contact treatment addresses a major complication frequently associated with various surgeries such as knee and hip replacements, and orthopedic trauma cases requiring plates, rods, and/or nails. The technology is particularly important and timely given the rise in the aging population, longer life expectancy, and the rapid increase in the number of orthopedic procedures being performed every year. Solenic's AMF  technology has been designated a Breakthrough Device by the U.S. FDA. It has the potential to completely replace the costly and risky two-step revision surgical procedure, which is the current standard of care for chronic infections on medical implants. Solenic Medical, Inc. is a VIC Technology Venture Development™ portfolio company.